[Analysis of Clinical Prognostic Factor for 99 Patients with Metastases of Proximal Femur].

Yi Yang,Wei Guo,Ran Wei

DOI: https://doi.org/10.3969/j.issn.1671-167x.2012.06.019

2012-01-01

Abstract:OBJECTIVE:To identify the clinical features and independent predictors of survival in patients with metastases of proximal femur.METHODS:In the study, 99 patients with proximal femoral metastatic lesions from 2003 to 2011 were analyzed retrospectively. The median age of patients was 56 years old (15-87 years old), and the most common diagnosis was lung cancer, followed by breast cancer. The overall survival rate after bone metastases was calculated using the Kaplan-Meier method. The prognostic factors were identified by univariate analysis using a Log-rank test and by multivariate analysis using Cox proportional hazards regression models.RESULTS:The 0.5-, 1- and 2-year survival rates were 55.7%, 24.3% and 7.7%, respectively, with an average survival time of 10.34 months for patients with metastases of proximal femur. In univariate analysis, the number of bone lesions, viscera metastases, and sensitivity to hormone therapy of primary tumor were correlated with prognosis. By multivariate analysis using Cox regression, the dependence to hormone therapy of primary tumor was the only independent prognostic factor.CONCLUSION:Patients with femoral metastatic lesions can be operated safely and with acceptable complication rates. The prognostic factor analysis will help us to determine the appropriate surgical treatment for proximal femoral metastases.